Lawyer profile
Christopher Mikson
DLA Piper
- Firm
- DLA Piper
- Practice
- capital markets, FDA
- Office
- Philadelphia, Washington DC, Washington, D.C.
- Active in the record
- 2020 to 2026
Deal experience
Sectors
Jurisdictions
Deals
6 announced deals in the record DLA Piper advises Kartos Therapeutics in acquisition by Ipsen for up to US$1.75 billion 1 Jul 2026
DLA Piper advises Dentsply Sirona in public offering of US$550 million junior subordinated notes 22 Jul 2025
DLA Piper advises Titan Partners in an underwritten public offering for Owlet, Inc. 18 Sept 2024
DLA Piper advises Cantor Fitzgerald in Zura Bio’s warrant exchange offer and consent solicitation 16 Aug 2024
DLA Piper advises Jones in Elicio Therapeutics’ US$40 million ATM and US$11.5 million public offering 16 Jul 2024
DLA Piper advises Arlington Capital Partners in majority investment in Everest Clinical Research Corporation 21 Dec 2020
Deal alerts PRO
Get an email when Christopher Mikson is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile